Literature DB >> 28906208

Pattern-recognition receptors: signaling pathways and dysregulation in canine chronic enteropathies-brief review.

Romy M Heilmann1,2, Karin Allenspach1,2.   

Abstract

Pattern-recognition receptors (PRRs) are expressed by innate immune cells and recognize pathogen-associated molecular patterns (PAMPs) as well as endogenous damage-associated molecular pattern (DAMP) molecules. With a large potential for synergism or convergence between their signaling pathways, PRRs orchestrate a complex interplay of cellular mediators and transcription factors, and thus play a central role in homeostasis and host defense. Aberrant activation of PRR signaling, mutations of the receptors and/or their downstream signaling molecules, and/or DAMP/PAMP complex-mediated receptor signaling can potentially lead to chronic auto-inflammatory diseases or development of cancer. PRR signaling pathways appear to also present an interesting new avenue for the modulation of inflammatory responses and to serve as potential novel therapeutic targets. Evidence for a dysregulation of the PRR toll-like receptor (TLR)2, TLR4, TLR5, and TLR9, nucleotide-binding oligomerization domain-containing protein (NOD)2, and the receptor of advanced glycation end products (RAGE) exists in dogs with chronic enteropathies. We describe the TLR, NOD2, and RAGE signaling pathways and evaluate the current veterinary literature-in comparison to human medicine-to determine the role of TLRs, NOD2, and RAGE in canine chronic enteropathies.

Entities:  

Keywords:  Chronic enteropathy; NOD-like receptor; damage-associated molecular pattern molecule; inflammatory bowel disease; receptor for advanced glycation end products; toll-like receptor

Mesh:

Substances:

Year:  2017        PMID: 28906208     DOI: 10.1177/1040638717728545

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  14 in total

1.  Association between serum soluble receptor for advanced glycation end-products (RAGE) deficiency and severity of clinicopathologic evidence of canine chronic inflammatory enteropathy.

Authors:  Angela Isabel Cabrera-García; Jan S Suchodolski; Jörg M Steiner; Romy M Heilmann
Journal:  J Vet Diagn Invest       Date:  2020-07-27       Impact factor: 1.279

2.  Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies.

Authors:  Romy M Heilmann; Nora Berghoff; Joanne Mansell; Niels Grützner; Nolie K Parnell; Corinne Gurtner; Jan S Suchodolski; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-02-20       Impact factor: 3.333

3.  Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment.

Authors:  Katja Kalenyak; Romy M Heilmann; Chris H A van de Lest; Jos F Brouwers; Iwan A Burgener
Journal:  PLoS One       Date:  2019-04-16       Impact factor: 3.240

Review 4.  Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies.

Authors:  Timothy M Fan; Kimberly A Selting
Journal:  Front Oncol       Date:  2019-01-15       Impact factor: 6.244

Review 5.  RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy.

Authors:  Wioletta Olejarz; Dominika Łacheta; Alicja Głuszko; Ewa Migacz; Wojciech Kukwa; Mirosław J Szczepański; Piotr Tomaszewski; Grażyna Nowicka
Journal:  Biomed Res Int       Date:  2018-08-26       Impact factor: 3.411

Review 6.  Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs.

Authors:  Romy M Heilmann; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

7.  Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease.

Authors:  Alexandros Ο Konstantinidis; Dimitra Pardali; Katerina K Adamama-Moraitou; Maria Gazouli; Chrysostomos I Dovas; Evangelia Legaki; Georgia D Brellou; Ioannis Savvas; Albert E Jergens; Timoleon S Rallis; Karin Allenspach
Journal:  BMC Vet Res       Date:  2020-02-22       Impact factor: 2.741

8.  TLR4 contributes to the damage of cartilage and subchondral bone in discectomy-induced TMJOA mice.

Authors:  Xin Liu; Heng-Xing Cai; Pin-Yin Cao; Yaping Feng; Heng-Hua Jiang; Li Liu; Jin Ke; Xing Long
Journal:  J Cell Mol Med       Date:  2020-09-11       Impact factor: 5.310

9.  Lysophosphatidic acid-RAGE axis promotes lung and mammary oncogenesis via protein kinase B and regulating tumor microenvironment.

Authors:  Rashmi Ray; Nitish Jangde; Satyendra Kumar Singh; Sunita Sinha; Vivek Rai
Journal:  Cell Commun Signal       Date:  2020-10-27       Impact factor: 5.712

Review 10.  What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?

Authors:  Carina Sacoor; Luís Meireles Barros; Liliana Montezinho
Journal:  Open Vet J       Date:  2020-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.